- decreased fasting circulating glucose level / IMPC
- increased body length / IMPC
- increased lean body mass / IMPC
- decreased circulating glycerol level / IMPC
- increased circulating chloride level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased circulating amylase level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating magnesium level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased circulating glucose level / IMPC
- decreased total body fat amount / IMPC
- decreased circulating free fatty acids level / IMPC
C57BL/6N-Atm1Brd Cpgi5563tm1(NCC)WCS/WtsiH
Status | Available to order |
EMMA ID | EM:10955 |
International strain name | C57BL/6N-Atm1Brd Cpgi5563tm1(NCC)WCS/WtsiH |
Alternative name | EPD01018_3_B07 |
Strain type | |
Allele/Transgene symbol | Cpgi5563tm1(NCC)WCS |
Gene/Transgene symbol | Cpgi5563 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from Sanger Institute ES clone EPD01018_3_B07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).